New insights into mechanisms underlying nitrate tolerance (Q40991742)

25 September 2017

1 reference

title

New insights into mechanisms underlying nitrate tolerance (English)

1 reference

25 September 2017

Münzel T

1

1 reference

25 September 2017

Kurz S

series ordinal

2

1 reference

25 September 2017

Heitzer T

series ordinal

3

1 reference

25 September 2017

Harrison DG

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

American Journal of Cardiology

25 September 2017

1 reference

25 September 2017

77

1 reference

25 September 2017

13

1 reference

25 September 2017

24C-30C

1 reference

Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Antianginal effects of intravenous nitroglycerin over 24 hours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

A reappraisal of nitrate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Desensitization to nitroglycerin in vascular smooth muscle from rat and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Adrenaline Toxicity in Mice: Sensitization of α1 Adrenoreceptors by Nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Protein kinase C of smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Downregulation of endothelin receptors by autocrine production of endothelin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

Reduced Nitric Oxide Release Causes Nitrate Tolerance in the Intact Coronary Circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900185-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(96)00185-3

1 reference

25 September 2017

1 reference